default author photo

Mario Luiz Marques-Piubelli

University of Texas at Houston - Department of Translational Molecular Pathology

Houston, TX

United States

SCHOLARLY PAPERS

2

DOWNLOADS

125

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor Immunity

Number of pages: 70 Posted: 19 Mar 2021
University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of General Internal Medicine, University of Texas at Houston - Department of Immunology, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Gastroenterology, Hepatology, and Nutrition, MD Anderson Cancer Center - Department of Gastroenterology, Hepatology and Nutrition, University of Texas at Houston - Pharmacy Clinical Programs, University of Texas at Houston - Pharmacy Clinical Programs, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology, University of Texas at Houston - Department of Melanoma Medical Oncology and University of Texas at Houston - Department of Melanoma Medical Oncology
Downloads 92 (730,864)

Abstract:

Loading...

Immunity, Toxicity, Colitis, Arthritis, Immune checkpoint blockade, Interleukin-6, Melanoma, TC1/TC-17, Th1/Th17, EAE

2.

Targetable Cellular Etiology of Prolonged Cytopenia Following CD19 CAR T-Cell Therapy

Number of pages: 37 Posted: 09 Nov 2022
University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma/Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma and University of Texas at Houston - Department of Lymphoma and Myeloma
Downloads 33 (1,277,121)

Abstract:

Loading...

CAR T-cell, B-cell lymphoma, Cytopenia, Interferon